{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:27:12Z","timestamp":1787315232356,"version":"build-2736575974"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2003,5,1]]},"DOI":"10.1038\/nrd1085","type":"journal-article","created":{"date-parts":[[2003,5,15]],"date-time":"2003-05-15T13:19:25Z","timestamp":1053004765000},"page":"379-390","source":"Crossref","is-referenced-by-count":178,"title":["Pharmacological strategies for muscular dystrophy"],"prefix":"10.1038","volume":"2","author":[{"given":"Tejvir S.","family":"Khurana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnrd1085_CR1","first-page":"5","volume":"11","author":"GBA Duchenne","year":"1868","unstructured":"Duchenne, G. B. A. Recherches sur la paralysie musculaire pseudohypertrophique ou paralysie myo-sclerosique. Arch. Gen. Med. 11, 5\u2013528 (1868).","journal-title":"Arch. Gen. Med."},{"key":"BFnrd1085_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/323646a0","volume":"323","author":"AP Monaco","year":"1986","unstructured":"Monaco, A. P. et al. Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature 323, 646\u2013650 (1986).","journal-title":"Nature"},{"key":"BFnrd1085_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","volume":"51","author":"EP Hoffman","year":"1987","unstructured":"Hoffman, E. P., Brown, R. H. & Kunkel, L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919\u2013928 (1987).","journal-title":"Cell"},{"key":"BFnrd1085_CR4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0092-8674(88)90383-2","volume":"53","author":"M Koenig","year":"1988","unstructured":"Koenig, M., Monaco, A. P. & Kunkel, L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219\u2013226 (1988). References 1\u20134 are classic papers describing DMD and elucidating its cause.","journal-title":"Cell"},{"key":"BFnrd1085_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/339055a0","volume":"339","author":"DR Love","year":"1989","unstructured":"Love, D. R. et al. An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339, 55\u201358 (1989).","journal-title":"Nature"},{"key":"BFnrd1085_CR6","doi-asserted-by":"publisher","first-page":"16717","DOI":"10.1016\/S0021-9258(17)44816-2","volume":"265","author":"TS Khurana","year":"1990","unstructured":"Khurana, T. S., Hoffman, E. P. & Kunkel, L. M. Identification of a chromosome 6-encoded dystrophin-related protein. J. Biol. Chem. 265, 16717\u201316720 (1990).","journal-title":"J. Biol. Chem."},{"key":"BFnrd1085_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/360591a0","volume":"360","author":"JM Tinsley","year":"1992","unstructured":"Tinsley, J. M. et al. Primary structure of dystrophin-related protein. Nature 360, 591\u2013593 (1992). References 5\u20137 describe the identification of the dystrophin-related protein utrophin.","journal-title":"Nature"},{"key":"BFnrd1085_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ng0696-223","volume":"13","author":"RG Roberts","year":"1996","unstructured":"Roberts, R. G. et al. Characterization of DRP2, a novel human dystrophin homologue. Nature Genet. 13, 223\u2013226 (1996).","journal-title":"Nature Genet."},{"key":"BFnrd1085_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/hmg\/3.5.841-a","volume":"3","author":"TS Khurana","year":"1994","unstructured":"Khurana, T. S. et al. (CA) repeat polymorphism in the chromosome 18 encoded dystrophin-like protein. Hum. Mol. Genet. 3, 841 (1994).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd1085_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/hmg\/5.4.489","volume":"5","author":"PH Sadoulet","year":"1996","unstructured":"Sadoulet, P. H., Khurana, T. S., Cohen, J. B. & Kunkel, L. M. Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum. Mol. Genet. 5, 489\u2013496 (1996).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd1085_CR11","doi-asserted-by":"publisher","first-page":"7802","DOI":"10.1074\/jbc.271.13.7802","volume":"271","author":"DJ Blake","year":"1996","unstructured":"Blake, D. J., Nawrotzki, R., Peters, M. F., Froehner, S. C. & Davies, K. E. Isoform diversity of dystrobrevin, the murine 87-kDa postsynaptic protein. J. Biol. Chem. 271, 7802\u20137810 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnrd1085_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(95)90344-5","volume":"80","author":"KP Campbell","year":"1995","unstructured":"Campbell, K. P. Three muscular dystrophies: loss of cytoskeletal extracellular matrix linkage. Cell 80, 675\u2013679 (1995).","journal-title":"Cell"},{"key":"BFnrd1085_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","volume":"66","author":"JM Ervasti","year":"1991","unstructured":"Ervasti, J. M. & Campbell, K. P. Membrane organization of the dystrophin\u2013glycoprotein complex. Cell 66, 1121\u20131131 (1991).","journal-title":"Cell"},{"key":"BFnrd1085_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/360588a0","volume":"360","author":"K Matsumura","year":"1992","unstructured":"Matsumura, K., Ervasti, J. M., Ohlendieck, K., Kahl, S. D. & Campbell, K. P. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360, 588\u2013591 (1992).","journal-title":"Nature"},{"key":"BFnrd1085_CR15","volume-title":"Duchenne Muscular Dystrophy","author":"AEH Emery","year":"1993","unstructured":"Emery, A. E. H. Duchenne Muscular Dystrophy (Oxford University Press, 1993)."},{"key":"BFnrd1085_CR16","volume-title":"Myology","author":"AG Engel","year":"1994","unstructured":"Engel, A. G. & Franzini-Armstrong, C. Myology (McGraw\u2013Hill, New York, 1994)."},{"key":"BFnrd1085_CR17","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/ajmg.1320250407","volume":"25","author":"G Karpati","year":"1986","unstructured":"Karpati, G. & Carpenter, S. Small-calibre skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am. J. Med. Genet. 25, 653\u2013658 (1986).","journal-title":"Am. J. Med. Genet."},{"key":"BFnrd1085_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/ana.410320418","volume":"32","author":"HJ Kaminski","year":"1992","unstructured":"Kaminski, H. J., al-Hakim, M., Leigh, R. J., Katirji, M. B. & Ruff, R. L. Extraocular muscles are spared in advanced Duchenne dystrophy. Ann. Neurol. 32, 586\u2013588 (1992).","journal-title":"Ann. Neurol."},{"key":"BFnrd1085_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1084\/jem.182.2.467","volume":"182","author":"TS Khurana","year":"1995","unstructured":"Khurana, T. S. et al. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J. Exp. Med. 182, 467\u2013475 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnrd1085_CR20","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/hmg\/9.16.2459","volume":"9","author":"V Allamand","year":"2000","unstructured":"Allamand, V. & Campbell, K. P. Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum. Mol. Genet. 9, 2459\u20132467 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd1085_CR21","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.81.4.1189","volume":"81","author":"G Bulfield","year":"1984","unstructured":"Bulfield, G., Siller, W. G., Wight, P. A. & Moore, K. J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl Acad. Sci. USA 81, 1189\u20131192 (1984).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/334154a0","volume":"334","author":"BJ Cooper","year":"1988","unstructured":"Cooper, B. J. et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334, 154\u2013156 (1988).","journal-title":"Nature"},{"key":"BFnrd1085_CR23","first-page":"909","volume":"135","author":"JL Carpenter","year":"1989","unstructured":"Carpenter, J. L. et al. Feline muscular dystrophy with dystrophin deficiency. Am. J. Pathol. 135, 909\u2013919 (1989). References 21\u201323 identified genuine animal models for DMD that are invaluable for preclinical therapeutic studies.","journal-title":"Am. J. Pathol."},{"key":"BFnrd1085_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0960-8966(99)00011-5","volume":"9","author":"SJ Schatzberg","year":"1999","unstructured":"Schatzberg, S. J. et al. Molecular analysis of a spontaneous dystrophin 'knockout' dog. Neuromuscul. Disord. 9, 289\u2013295 (1999).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR25","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1073\/pnas.86.4.1292","volume":"86","author":"VM Chapman","year":"1989","unstructured":"Chapman, V. M., Miller, D. R., Armstrong, D. & Caskey, C. T. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc. Natl Acad. Sci. USA 86, 1292\u20131296 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/352536a0","volume":"352","author":"HH Stedman","year":"1991","unstructured":"Stedman, H. H. et al. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536\u2013539 (1991).","journal-title":"Nature"},{"key":"BFnrd1085_CR27","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/BF00121296","volume":"14","author":"P Moens","year":"1993","unstructured":"Moens, P., Baatsen, P. H. & Marechal, G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J. Muscle Res. Cell Motil. 14, 446\u2013451 (1993).","journal-title":"J. Muscle Res. Cell Motil."},{"key":"BFnrd1085_CR28","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M. & Sweeney, H. L. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA 90, 3710\u20133714 (1993). References 26\u201328 characterize functional deficits in mdx muscle and provide ex vivo experimental paradigms for evaluation of therapeutic interventions.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR29","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/978-1-4684-6039-1_45","volume":"453","author":"JM Gillis","year":"1998","unstructured":"Gillis, J. M. & Deconinck, N. The physiological evaluation of gene therapies of dystrophin-deficient muscles. Adv. Exp. Med. Biol. 453, 411\u2013416; discussion 417 (1998).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrd1085_CR30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-201x.2001.00838.x","volume":"171","author":"TO Krag","year":"2001","unstructured":"Krag, T. O., Gyrd-Hansen, M. & Khurana, T. S. Harnessing the potential of dystrophin-related proteins for ameliorating Duchenne's muscular dystrophy. Acta Physiol. Scand. 171, 349\u2013358 (2001).","journal-title":"Acta Physiol. Scand."},{"issue":"Suppl. 1","key":"BFnrd1085_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0960-8966(02)00088-3","volume":"12","author":"JM Gillis","year":"2002","unstructured":"Gillis, J. M. Multivariate evaluation of the functional recovery obtained by the overexpression of utrophin in skeletal muscles of the mdx mouse. Neuromuscul. Disord. 12 Suppl. 1, 90\u201394 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0092-8674(00)80532-2","volume":"90","author":"AE Deconinck","year":"1997","unstructured":"Deconinck, A. E. et al. Utrophin\u2013dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90, 717\u2013727 (1997).","journal-title":"Cell"},{"key":"BFnrd1085_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","volume":"90","author":"RM Grady","year":"1997","unstructured":"Grady, R. M. et al. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90, 729\u2013738 (1997).","journal-title":"Cell"},{"key":"BFnrd1085_CR34","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/labinvest.3780092","volume":"80","author":"J Morrison","year":"2000","unstructured":"Morrison, J., Lu, Q. L., Pastoret, C., Partridge, T. & Bou-Gharios, G. T-cell-dependent fibrosis in the mdx dystrophic mouse. Lab. Invest. 80, 881\u2013891 (2000).","journal-title":"Lab. Invest."},{"key":"BFnrd1085_CR35","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1006\/jmbi.1998.2406","volume":"285","author":"NH Keep","year":"1999","unstructured":"Keep, N. H., Norwood, F. L., Moores, C. A., Winder, S. J. & Kendrick-Jones, J. The 2.0 A structure of the second calponin homology domain from the actin-binding region of the dystrophin homologue utrophin. J. Mol. Biol. 285, 1257\u20131264 (1999).","journal-title":"J. Mol. Biol."},{"key":"BFnrd1085_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1242\/jcs.108.1.63","volume":"108","author":"SJ Winder","year":"1995","unstructured":"Winder, S. J. et al. Utrophin actin binding domain: analysis of actin binding and cellular targeting. J. Cell Sci. 108, 63\u201371 (1995).","journal-title":"J. Cell Sci."},{"key":"BFnrd1085_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-5793(95)00398-S","volume":"369","author":"SJ Winder","year":"1995","unstructured":"Winder, S. J., Gibson, T. J. & Kendrick, J. J. Dystrophin and utrophin: the missing links. FEBS Lett. 369, 27\u201333 (1995).","journal-title":"FEBS Lett."},{"key":"BFnrd1085_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00028.2001","volume":"82","author":"DJ Blake","year":"2002","unstructured":"Blake, D. J., Weir, A., Newey, S. E. & Davies, K. E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev. 82, 291\u2013329 (2002).","journal-title":"Physiol. Rev."},{"key":"BFnrd1085_CR39","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1083\/jcb.150.6.1385","volume":"150","author":"ME Adams","year":"2000","unstructured":"Adams, M. E. et al. Absence of \u03b1-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin. J. Cell. Biol. 150, 1385\u20131398 (2000).","journal-title":"J. Cell. Biol."},{"key":"BFnrd1085_CR40","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1073\/pnas.88.8.3243","volume":"88","author":"DR Love","year":"1991","unstructured":"Love, D. R. et al. Tissue distribution of the dystrophin-related gene product and expression in the mdx and dy mouse. Proc. Natl Acad. Sci. USA 88, 3243\u20133247 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0960-8966(91)90023-L","volume":"1","author":"TS Khurana","year":"1991","unstructured":"Khurana, T. S. et al. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul. Disord. 1, 185\u2013194 (1991).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR42","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1083\/jcb.115.6.1695","volume":"115","author":"TM Nguyen","year":"1991","unstructured":"Nguyen, T. M. et al. Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines. J. Cell Biol. 115, 1695\u20131700 (1991).","journal-title":"J. Cell Biol."},{"key":"BFnrd1085_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0896-6273(91)90301-F","volume":"7","author":"K Ohlendieck","year":"1991","unstructured":"Ohlendieck, K. et al. Dystrophin-related protein is localized to neuromuscular junctions of adult skeletal muscle. Neuron 7, 499\u2013508 (1991).","journal-title":"Neuron"},{"key":"BFnrd1085_CR44","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1083\/jcb.115.2.411","volume":"115","author":"TJ Byers","year":"1991","unstructured":"Byers, T. J., Kunkel, L. M. & Watkins, S. C. The sub-cellular distribution of dystrophin in mouse skeletal, cardiac, and smooth muscle. J. Cell Biol. 115, 411\u2013421 (1991).","journal-title":"J. Cell Biol."},{"key":"BFnrd1085_CR45","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/00001756-199210000-00009","volume":"3","author":"GS Bewick","year":"1992","unstructured":"Bewick, G. S., Nicholson, L. V., Young, C., O'Donnell, E. & Slater, C. R. Different distributions of dystrophin and related proteins at nerve-muscle junctions. Neuroreport 3, 857\u2013860 (1992).","journal-title":"Neuroreport"},{"key":"BFnrd1085_CR46","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/BF02388063","volume":"25","author":"A Clerk","year":"1993","unstructured":"Clerk, A., Morris, G. E., Dubowitz, V., Davies, K. E. & Sewry, C. A. Dystrophin-related protein, utrophin, in normal and dystrophic human fetal skeletal muscle. Histochem. J. 25, 554\u2013561 (1993).","journal-title":"Histochem. J."},{"key":"BFnrd1085_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0960-8966(93)90106-T","volume":"3","author":"F Pons","year":"1993","unstructured":"Pons, F., Nicholson, L. V., Robert, A., Voit, T. & Leger, J. J. Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles. Neuromuscul. Disord. 3, 507\u2013514 (1993).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR48","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s004410000213","volume":"300","author":"V Radojevic","year":"2000","unstructured":"Radojevic, V., Lin, S. & Burgunder, J. M. Differential expression of dystrophin, utrophin, and dystrophin-associated proteins in human muscle culture. Cell Tissue Res. 300, 447\u2013457 (2000).","journal-title":"Cell Tissue Res."},{"key":"BFnrd1085_CR49","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1083\/jcb.136.4.883","volume":"136","author":"AE Deconinck","year":"1997","unstructured":"Deconinck, A. E. et al. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J. Cell. Biol. 136, 883\u2013894 (1997).","journal-title":"J. Cell. Biol."},{"key":"BFnrd1085_CR50","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1083\/jcb.136.4.871","volume":"136","author":"RM Grady","year":"1997","unstructured":"Grady, R. M., Merlie, J. P. & Sanes, J. R. Subtle neuromuscular defects in utrophin-deficient mice. J. Cell. Biol. 136, 871\u2013882 (1997).","journal-title":"J. Cell. Biol."},{"key":"BFnrd1085_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ng0598-79","volume":"19","author":"JA Rafael","year":"1998","unstructured":"Rafael, J. A., Tinsley, J. M., Potter, A. C., Deconinck, A. E. & Davies, K. E. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nature Genet. 19, 79\u201382 (1998).","journal-title":"Nature Genet."},{"key":"BFnrd1085_CR52","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley, J. et al. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Med. 4, 1441\u20131444 (1998).","journal-title":"Nature Med."},{"key":"BFnrd1085_CR53","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/384349a0","volume":"384","author":"JM Tinsley","year":"1996","unstructured":"Tinsley, J. M. et al. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature 384, 349\u2013353 (1996). Reference 53 provides the proof of principle that utrophin can functionally substitute for dystrophin in vivo.","journal-title":"Nature"},{"key":"BFnrd1085_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/sj.gt.3301066","volume":"7","author":"PM Wakefield","year":"2000","unstructured":"Wakefield, P. M. et al. Prevention of the dystrophic phenotype in dystrophin\/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene. Gene Ther. 7, 201\u2013204 (2000).","journal-title":"Gene Ther."},{"key":"BFnrd1085_CR55","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1093\/hmg\/2.11.1765","volume":"2","author":"M Pearce","year":"1993","unstructured":"Pearce, M. et al. The utrophin and dystrophin genes share similarities in genomic structure. Hum. Mol. Genet. 2, 1765\u20131772 (1993).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd1085_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00335-002-3044-z","volume":"14","author":"C Jimenez-Mallebrera","year":"2003","unstructured":"Jimenez-Mallebrera, C., Davies, K., Putt, W. & Edwards, Y. H. A study of short utrophin isoforms in mice deficient for full-length utrophin. Mamm. Genome 14, 47\u201360 (2003).","journal-title":"Mamm. Genome"},{"key":"BFnrd1085_CR57","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/nar\/24.9.1646","volume":"24","author":"CL Dennis","year":"1996","unstructured":"Dennis, C. L., Tinsley, J. M., Deconinck, A. E. & Davies, K. E. Molecular and functional analysis of the utrophin promoter. Nucleic Acids Res. 24, 1646\u20131652 (1996).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd1085_CR58","doi-asserted-by":"publisher","first-page":"14025","DOI":"10.1073\/pnas.96.24.14025","volume":"96","author":"EA Burton","year":"1999","unstructured":"Burton, E. A., Tinsley, J. M., Holzfeind, P. J., Rodrigues, N. R. & Davies, K. E. A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA 96, 14025\u201314030 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR59","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1074\/jbc.275.5.3168","volume":"275","author":"F Galvagni","year":"2000","unstructured":"Galvagni, F. & Oliviero, S. Utrophin transcription is activated by an intronic enhancer. J. Biol. Chem. 275, 3168\u20133172 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrd1085_CR60","doi-asserted-by":"publisher","first-page":"45285","DOI":"10.1074\/jbc.M205177200","volume":"277","author":"AP Weir","year":"2002","unstructured":"Weir, A. P., Burton, E. A., Harrod, G. & Davies, K. E. A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J. Biol. Chem. 277, 45285\u201345290 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrd1085_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-6273(01)00353-1","volume":"31","author":"L Schaeffer","year":"2001","unstructured":"Schaeffer, L., de Kerchove d'Exaerde, A. & Changeux, J. P. Targeting transcription to the neuromuscular synapse. Neuron 31, 15\u201322 (2001).","journal-title":"Neuron"},{"key":"BFnrd1085_CR62","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0959-4388(00)00210-5","volume":"11","author":"A Buonanno","year":"2001","unstructured":"Buonanno, A. & Fischbach, G. D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol. 11, 287\u2013296 (2001).","journal-title":"Curr. Opin. Neurobiol."},{"key":"BFnrd1085_CR63","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1073\/pnas.96.6.3223","volume":"96","author":"AO Gramolini","year":"1999","unstructured":"Gramolini, A. O. et al. Induction of utrophin gene expression by heregulin in skeletal muscle cells: role of the N-box motif and GA binding protein. Proc. Natl Acad. Sci. USA 96, 3223\u20133227 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR64","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1091\/mbc.10.6.2075","volume":"10","author":"TS Khurana","year":"1999","unstructured":"Khurana, T. S. et al. Activation of utrophin promoter by heregulin via the ets-related transcription factor complex GA-binding protein \u03b1\/\u03b2. Mol. Biol. Cell. 10, 2075\u20132086 (1999).","journal-title":"Mol. Biol. Cell."},{"key":"BFnrd1085_CR65","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1006\/jmbi.2000.4335","volume":"306","author":"F Galvagni","year":"2001","unstructured":"Galvagni, F., Capo, S. & Oliviero, S. Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter. J. Mol. Biol. 306, 985\u2013996 (2001).","journal-title":"J. Mol. Biol."},{"key":"BFnrd1085_CR66","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1093\/nar\/29.23.4843","volume":"29","author":"KJ Perkins","year":"2001","unstructured":"Perkins, K. J., Burton, E. A. & Davies, K. E. The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy. Nucleic Acids Res. 29, 4843\u20134850 (2001).","journal-title":"Nucleic Acids Res."},{"key":"BFnrd1085_CR67","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0022-510X(02)00038-2","volume":"197","author":"M Gyrd-Hansen","year":"2002","unstructured":"Gyrd-Hansen, M., Krag, T. O., Rosmarin, A. G. & Khurana, T. S. Sp1 and the ets-related transcription factor complex GABP \u03b1\/\u03b2 functionally cooperate to activate the utrophin promoter. J. Neurol. Sci. 197, 27\u201335 (2002).","journal-title":"J. Neurol. Sci."},{"key":"BFnrd1085_CR68","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0014-5793(03)00175-3","volume":"538","author":"KJ Perkins","year":"2003","unstructured":"Perkins, K. J. & Davies, K. E. Ets, Ap-1 and GATA factor families regulate the utrophin B promoter; potential regulatory mechanisms for endothelial-specific expression. FEBS Lett. 538, 168\u2013172 (2003).","journal-title":"FEBS Lett."},{"key":"BFnrd1085_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0960-8966(02)00217-1","volume":"13","author":"A Briguet","year":"2003","unstructured":"Briguet, A., Bleckmann, D., Bettan, M., Mermod, N. & Meier, T. Transcriptional activation of the utrophin promoter B by a constitutively active Ets-transcription factor. Neuromuscul. Disord. 13, 143\u2013150 (2003).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1006\/nbdi.1999.0256","volume":"6","author":"E Chaubourt","year":"1999","unstructured":"Chaubourt, E. et al. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Neurobiol. Dis. 6, 499\u2013507 (1999).","journal-title":"Neurobiol. Dis."},{"key":"BFnrd1085_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0928-4257(01)00079-1","volume":"96","author":"E Chaubourt","year":"2002","unstructured":"Chaubourt, E. et al. Muscular nitric oxide synthase (muNOS) and utrophin. J. Physiol. Paris 96, 43\u201352 (2002).","journal-title":"J. Physiol. Paris"},{"key":"BFnrd1085_CR72","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1083\/jcb.152.6.1207","volume":"152","author":"DJ Burkin","year":"2001","unstructured":"Burkin, D. J., Wallace, G. Q., Nicol, K. J., Kaufman, D. J. & Kaufman, S. J. Enhanced expression of the \u03b17\u03b21 integrin reduces muscular dystrophy and restores viability in dystrophic mice. J. Cell. Biol. 152, 1207\u20131218 (2001).","journal-title":"J. Cell. Biol."},{"key":"BFnrd1085_CR73","doi-asserted-by":"publisher","first-page":"5616","DOI":"10.1073\/pnas.082613599","volume":"99","author":"HH Nguyen","year":"2002","unstructured":"Nguyen, H. H., Jayasinha, V., Xia, B., Hoyte, K. & Martin, P. T. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice. Proc. Natl Acad. Sci. USA 99, 5616\u20135621 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR74","doi-asserted-by":"publisher","first-page":"C1300","DOI":"10.1152\/ajpcell.2001.281.4.C1300","volume":"281","author":"AO Gramolini","year":"2001","unstructured":"Gramolini, A. O., Belanger, G., Thompson, J. M., Chakkalakal, J. V. & Jasmin, B. J. Increased expression of utrophin in a slow vs. a fast muscle involves posttranscriptional events. Am. J. Physiol. Cell. Physiol. 281, C1300\u2013C1309 (2001).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"BFnrd1085_CR75","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1016\/S0960-8966(02)00089-5","volume":"12","author":"I Courdier-Fruh","year":"2002","unstructured":"Courdier-Fruh, I., Barman, L., Briguet, A. & Meier, T. Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers. Neuromuscul. Disord. 12, S95\u2013S104 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR76","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0960-8966(01)00220-6","volume":"11","author":"R Fisher","year":"2001","unstructured":"Fisher, R. et al. Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Neuromuscul. Disord. 11, 713\u2013721 (2001).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR77","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1093\/hmg\/11.26.3333","volume":"11","author":"S Squire","year":"2002","unstructured":"Squire, S. et al. Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system. Hum. Mol. Genet. 11, 3333\u20133344 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd1085_CR78","unstructured":"Cerletti, M. et al. The dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther. (In the press)."},{"key":"BFnrd1085_CR79","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/S0960-8966(02)00082-2","volume":"12","author":"C Thioudellet","year":"2002","unstructured":"Thioudellet, C., Blot, S., Squiban, P., Fardeau, M. & Braun, S. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne\/Becker muscular dystrophies. Part I: rationale. Neuromuscul. Disord. 12, S49\u2013S51 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR80","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/S0960-8966(02)00081-0","volume":"12","author":"NB Romero","year":"2002","unstructured":"Romero, N. B. et al. Current protocol of a research phase I clinical trial of full-length dystrophin plasmid DNA in Duchenne\/Becker muscular dystrophies. Part II: clinical protocol. Neuromuscul. Disord. 12, S45\u2013S48 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR81","first-page":"624","volume":"71","author":"W Barthelmai","year":"1965","unstructured":"Barthelmai, W. On the effect of corticoid administration on creatine phosphokinase in progressive muscular dystrophy. Verh. Dtsch Ges. Inn. Med. 71, 624\u2013626 (1965).","journal-title":"Verh. Dtsch Ges. Inn. Med."},{"key":"BFnrd1085_CR82","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S0140-6736(74)90071-3","volume":"2","author":"DB Drachman","year":"1974","unstructured":"Drachman, D. B., Toyka, K. V. & Myer, E. Prednisone in Duchenne muscular dystrophy. Lancet 2, 1409\u20131412 (1974). References 81\u201382 describe the use of steroids in pharmacological therapy of DMD.","journal-title":"Lancet"},{"key":"BFnrd1085_CR83","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJM198906153202405","volume":"320","author":"JR Mendell","year":"1989","unstructured":"Mendell, J. R. et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N. Engl. J. Med. 320, 1592\u20131597 (1989).","journal-title":"N. Engl. J. Med."},{"key":"BFnrd1085_CR84","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/0960-8966(93)90117-3","volume":"3","author":"A Sansome","year":"1993","unstructured":"Sansome, A., Royston, P. & Dubowitz, V. Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule. Neuromuscul. Disord. 3, 567\u2013569 (1993).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR85","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/1097-4598(200009)23:9<1344::AID-MUS4>3.0.CO;2-F","volume":"23","author":"MD Bonifati","year":"2000","unstructured":"Bonifati, M. D. et al. A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 23, 1344\u20131347 (2000).","journal-title":"Muscle Nerve"},{"key":"BFnrd1085_CR86","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/oso\/9780192632913.003.0012","volume-title":"The Muscular Dystrophies","author":"AY Manzur","year":"2001","unstructured":"Manzur, A. Y. in The Muscular Dystrophies (ed. Emery, A. E. H.) 223\u2013246 (Oxford University Press, 2001)."},{"key":"BFnrd1085_CR87","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1212\/WNL.28.5.439","volume":"28","author":"JB Bodensteiner","year":"1978","unstructured":"Bodensteiner, J. B. & Engel, A. G. Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology 28, 439\u2013446 (1978).","journal-title":"Neurology"},{"key":"BFnrd1085_CR88","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1152\/physiolgenomics.00115.2001","volume":"9","author":"MD Fischer","year":"2002","unstructured":"Fischer, M. D. et al. Expression profiling reveals metabolic and structural components of extraocular muscles. Physiol. Genomics 9, 71\u201384 (2002).","journal-title":"Physiol. Genomics"},{"key":"BFnrd1085_CR89","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.2173137","volume":"250","author":"PY Fong","year":"1990","unstructured":"Fong, P. Y., Turner, P. R., Denetclaw, W. F. & Steinhardt, R. A. Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250, 673\u2013676 (1990).","journal-title":"Science"},{"key":"BFnrd1085_CR90","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF00232023","volume":"133","author":"PR Turner","year":"1993","unstructured":"Turner, P. R., Schultz, R., Ganguly, B. & Steinhardt, R. A. Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. J. Membr. Biol. 133, 243\u2013251 (1993).","journal-title":"J. Membr. Biol."},{"key":"BFnrd1085_CR91","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1113\/jphysiol.2002.020487","volume":"542","author":"F De Backer","year":"2002","unstructured":"De Backer, F., Vandebrouck, C., Gailly, P. & Gillis, J. M. Long-term study of Ca2+ homeostasis and of survival in collagenase-isolated muscle fibres from normal and mdx mice. J. Physiol. 542, 855\u2013865 (2002).","journal-title":"J. Physiol."},{"key":"BFnrd1085_CR92","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/mus.880140603","volume":"14","author":"TE Bertorini","year":"1991","unstructured":"Bertorini, T. E. et al. Effect of dantrolene in Duchenne muscular dystrophy. Muscle Nerve 14, 503\u2013507 (1991).","journal-title":"Muscle Nerve"},{"key":"BFnrd1085_CR93","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<106::AID-MUS14>3.0.CO;2-D","volume":"23","author":"MA Badalamente","year":"2000","unstructured":"Badalamente, M. A. & Stracher, A. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23, 106\u2013111 (2000).","journal-title":"Muscle Nerve"},{"key":"BFnrd1085_CR94","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/hmg\/11.21.2645","volume":"11","author":"MJ Spencer","year":"2002","unstructured":"Spencer, M. J. & Mellgren, R. L. Overexpression of a calpastatin transgene in mdx muscle reduces dystrophic pathology. Hum. Mol. Genet. 11, 2645\u20132655 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd1085_CR95","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/S0140-6736(76)92781-1","volume":"1","author":"K Wrogemann","year":"1976","unstructured":"Wrogemann, K. & Pena, S. D. Mitochondrial calcium overload: A general mechanism for cell-necrosis in muscle diseases. Lancet 1, 672\u2013674 (1976).","journal-title":"Lancet"},{"key":"BFnrd1085_CR96","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ana.410160206","volume":"16","author":"K Arahata","year":"1984","unstructured":"Arahata, K. & Engel, A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann. Neurol. 16, 193\u2013208 (1984).","journal-title":"Ann. Neurol."},{"key":"BFnrd1085_CR97","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/ana.410160207","volume":"16","author":"AG Engel","year":"1984","unstructured":"Engel, A. G. & Arahata, K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16, 209\u2013215 (1984).","journal-title":"Ann. Neurol."},{"key":"BFnrd1085_CR98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.410190203","volume":"19","author":"K Arahata","year":"1986","unstructured":"Arahata, K. & Engel, A. G. Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann. Neurol. 19, 112\u2013125 (1986). References 96\u201398 suggest a role for cellular immunity in DMD.","journal-title":"Ann. Neurol."},{"key":"BFnrd1085_CR99","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/0022-510X(94)90050-7","volume":"122","author":"J Gorospe","year":"1994","unstructured":"Gorospe, J., Tharp, M. D., Hinckley, J., Kornegay, J. N. & Hoffman, E. P. A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice. J. Neurol. Sci. 122, 44\u201356 (1994).","journal-title":"J. Neurol. Sci."},{"key":"BFnrd1085_CR100","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1083\/jcb.151.6.1321","volume":"151","author":"Y-W Chen","year":"2000","unstructured":"Chen, Y. -W., Zhao, P., Borup, R. & Hoffman, E. P. Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology. J. Cell. Biol. 151, 1321\u20131326 (2000).","journal-title":"J. Cell. Biol."},{"key":"BFnrd1085_CR101","doi-asserted-by":"publisher","first-page":"15000","DOI":"10.1073\/pnas.192571199","volume":"99","author":"JN Haslett","year":"2002","unstructured":"Haslett, J. N. et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc. Natl Acad. Sci. USA 99, 15000\u201315005 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR102","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ana.410350320","volume":"35","author":"PA D'Amore","year":"1994","unstructured":"D'Amore, P. A. et al. Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann. Neurol. 35, 362\u2013365 (1994).","journal-title":"Ann. Neurol."},{"key":"BFnrd1085_CR103","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/clim.2000.4966","volume":"98","author":"MJ Spencer","year":"2001","unstructured":"Spencer, M. J., Montecino-Rodriguez, E., Dorshkind, K. & Tidball, J. G. Helper (CD4+) and cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle. Clin. Immunol. 98, 235\u2013243 (2001).","journal-title":"Clin. Immunol."},{"key":"BFnrd1085_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-510X(95)00089-K","volume":"131","author":"JA Granchelli","year":"1995","unstructured":"Granchelli, J. A., Pollina, C. & Hudecki, M. S. Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity. J. Neurol. Sci. 131, 1\u20137 (1995).","journal-title":"J. Neurol. Sci."},{"key":"BFnrd1085_CR105","first-page":"287","volume":"91","author":"JA Granchelli","year":"1996","unstructured":"Granchelli, J. A., Avosso, D. L., Hudecki, M. S. & Pollina, C. Cromolyn increases strength in exercised mdx mice. Res. Commun. Mol. Pathol. Pharmacol. 91, 287\u2013296 (1996).","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"BFnrd1085_CR106","doi-asserted-by":"publisher","first-page":"C865","DOI":"10.1152\/ajpcell.1994.267.3.C865","volume":"267","author":"RJ Zeman","year":"1994","unstructured":"Zeman, R. J., Zhang, Y. & Etlinger, J. D. Clenbuterol, a \u03b22-agonist, retards wasting and loss of contractility in irradiated dystrophic mdx muscle. Am. J. Physiol. 267, C865\u2013C868 (1994).","journal-title":"Am. J. Physiol."},{"key":"BFnrd1085_CR107","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0014-5793(98)01399-4","volume":"439","author":"SM Pulido","year":"1998","unstructured":"Pulido, S. M. et al. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett. 439, 357\u2013362 (1998).","journal-title":"FEBS Lett."},{"key":"BFnrd1085_CR108","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1212\/WNL.54.9.1848","volume":"54","author":"MC Walter","year":"2000","unstructured":"Walter, M. C. et al. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology 54, 1848\u20131850 (2000).","journal-title":"Neurology"},{"key":"BFnrd1085_CR109","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1172\/JCI7866","volume":"104","author":"ER Barton-Davis","year":"1999","unstructured":"Barton-Davis, E. R., Cordier, L., Shoturma, D. I., Leland, S. E. & Sweeney, H. L. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J. Clin. Invest. 104, 375\u2013381 (1999).","journal-title":"J. Clin. Invest."},{"key":"BFnrd1085_CR110","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.1023","volume":"49","author":"KR Wagner","year":"2001","unstructured":"Wagner, K. R. et al. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann. Neurol. 49, 706\u2013711 (2001).","journal-title":"Ann. Neurol."},{"key":"BFnrd1085_CR111","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1083\/jcb.200108071","volume":"157","author":"ER Barton","year":"2002","unstructured":"Barton, E. R., Morris, L., Musaro, A., Rosenthal, N. & Sweeney, H. L. Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice. J. Cell. Biol. 157, 137\u2013148 (2002).","journal-title":"J. Cell. Biol."},{"key":"BFnrd1085_CR112","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/S0002-9440(10)64502-6","volume":"161","author":"P Gregorevic","year":"2002","unstructured":"Gregorevic, P., Plant, D. R., Leeding, K. S., Bach, L. A. & Lynch, G. S. Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am. J. Pathol. 161, 2263\u20132272 (2002). References 111\u2013112 demonstrate increasing muscle mass as a therapeutic strategy in DMD.","journal-title":"Am. J. Pathol."},{"key":"BFnrd1085_CR113","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/jpet.102.041343","volume":"304","author":"A De Luca","year":"2003","unstructured":"De Luca, A. et al. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J. Pharmacol. Exp. Ther. 304, 453\u2013463 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrd1085_CR114","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/BF00539005","volume":"6","author":"C Charlier","year":"1995","unstructured":"Charlier, C. et al. The mh gene causing double-muscling in cattle maps to bovine chromosome 2. Mamm. Genome 6, 788\u2013792 (1995).","journal-title":"Mamm. Genome"},{"key":"BFnrd1085_CR115","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/ng0997-71","volume":"1","author":"L Grobet","year":"1997","unstructured":"Grobet, L. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nature Genet. 1, 71\u201374 (1997).","journal-title":"Nature Genet."},{"key":"BFnrd1085_CR116","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron, A. C., Lawler, A. M. & Lee, S. J. Regulation of skeletal muscle mass in mice by a new TGF-\u03b2 superfamily member. Nature 387, 83\u201390 (1997). References 115 and 116 identify myostatin as a potent regulator of muscle progenitor cells.","journal-title":"Nature"},{"key":"BFnrd1085_CR117","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0006-291X(02)00209-7","volume":"293","author":"M Nishi","year":"2002","unstructured":"Nishi, M. et al. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochem. Biophys. Res. Commun. 293, 247\u2013251 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrd1085_CR118","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0014-5793(00)01570-2","volume":"474","author":"X Zhu","year":"2000","unstructured":"Zhu, X., Hadhazy, M., Wehling, M., Tidball, J. G. & McNally, E. M. Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett. 474, 71\u201375 (2000).","journal-title":"FEBS Lett."},{"key":"BFnrd1085_CR119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/08977190109029114","volume":"18","author":"RS Thies","year":"2001","unstructured":"Thies, R. S. et al. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18, 251\u2013259 (2001).","journal-title":"Growth Factors"},{"key":"BFnrd1085_CR120","doi-asserted-by":"publisher","first-page":"9306","DOI":"10.1073\/pnas.151270098","volume":"98","author":"SJ Lee","year":"2001","unstructured":"Lee, S. J. Regulation of myostatin activity and muscle growth. Proc. Natl Acad. Sci. USA 98, 9306\u20139311 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR121","doi-asserted-by":"publisher","first-page":"40235","DOI":"10.1074\/jbc.M004356200","volume":"275","author":"M Thomas","year":"2000","unstructured":"Thomas, M. et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J. Biol. Chem. 275, 40235\u201340243 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrd1085_CR122","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1128\/MCB.22.20.7066-7082.2002","volume":"22","author":"MP Spiller","year":"2002","unstructured":"Spiller, M. P. et al. The myostatin gene is a downstream target gene of basic helix-loop-helix transcription factor MyoD. Mol. Cell Biol. 22, 7066\u20137082 (2002).","journal-title":"Mol. Cell Biol."},{"key":"BFnrd1085_CR123","doi-asserted-by":"publisher","first-page":"49831","DOI":"10.1074\/jbc.M204291200","volume":"277","author":"B Langley","year":"2002","unstructured":"Langley, B. et al. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277, 49831\u201349840 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrd1085_CR124","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich, S. et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 420, 418\u2013421 (2002). Reference 124 demonstrates myostatin blockade as a pharmacological strategy in DMD.","journal-title":"Nature"},{"key":"BFnrd1085_CR125","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1002\/ana.10385","volume":"52","author":"KR Wagner","year":"2002","unstructured":"Wagner, K. R., McPherron, A. C., Winik, N. & Lee, S. J. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann. Neurol. 52, 832\u2013836 (2002).","journal-title":"Ann. Neurol."},{"key":"BFnrd1085_CR126","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/S0960-8966(02)00094-9","volume":"12","author":"DM Escolar","year":"2002","unstructured":"Escolar, D. M., Henricson, E. K., Pasquali, L., Gorni, K. & Hoffman, E. P. Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG). Neuromuscul. Disord. 12, S147\u2013S154 (2002).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR127","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0960-8966(99)00126-1","volume":"10","author":"JA Granchelli","year":"2000","unstructured":"Granchelli, J. A., Pollina, C. & Hudecki, M. S. Pre-clinical screening of drugs using the mdx mouse. Neuromuscul. Disord. 10, 235\u2013239 (2000).","journal-title":"Neuromuscul. Disord."},{"key":"BFnrd1085_CR128","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/361647a0","volume":"361","author":"T Ragot","year":"1993","unstructured":"Ragot, T. et al. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361, 647\u2013650 (1993).","journal-title":"Nature"},{"key":"BFnrd1085_CR129","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1073\/pnas.98.1.42","volume":"98","author":"CJ Mann","year":"2001","unstructured":"Mann, C. J. et al. Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc. Natl Acad. Sci. USA 98, 42\u201347 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR130","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/hmg\/10.15.1547","volume":"10","author":"JC van Deutekom","year":"2001","unstructured":"van Deutekom, J. C. et al. Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum. Mol. Genet. 10, 1547\u20131554 (2001).","journal-title":"Hum. Mol. Genet."},{"key":"BFnrd1085_CR131","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/76448","volume":"18","author":"RJ Bartlett","year":"2000","unstructured":"Bartlett, R. J. et al. In vivo targeted repair of a point mutation in the canine dystrophin gene by a chimeric RNA\/DNA oligonucleotide. Nature Biotechnol. 18, 615\u2013622 (2000).","journal-title":"Nature Biotechnol."},{"key":"BFnrd1085_CR132","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1073\/pnas.97.10.5363","volume":"97","author":"TA Rando","year":"2000","unstructured":"Rando, T. A., Disatnik, M. H. & Zhou, L. Z. Rescue of dystrophin expression in mdx mouse muscle by RNA\/DNA oligonucleotides. Proc. Natl Acad. Sci. USA 97, 5363\u20135368 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrd1085_CR133","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/337176a0","volume":"337","author":"TA Partridge","year":"1989","unstructured":"Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P. & Kunkel, L. M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 337, 176\u2013179 (1989).","journal-title":"Nature"},{"key":"BFnrd1085_CR134","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s004290050237","volume":"199","author":"RE Bittner","year":"1999","unstructured":"Bittner, R. E. et al. Recruitment of bone-marrow-derived cells by skeletal and cardiac muscle in adult dystrophic mdx mice. Anat. Embryol. (Berl.) 199, 391\u2013396 (1999).","journal-title":"Anat. Embryol. (Berl.)"},{"key":"BFnrd1085_CR135","first-page":"390","volume":"401","author":"E Gussoni","year":"1999","unstructured":"Gussoni, E. et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 401, 390\u2013394 (1999). References 128\u2013135 describe a variety of gene and cell-based therapies for DMD.","journal-title":"Nature"},{"key":"BFnrd1085_CR136","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.1002\/j.1460-2075.1995.tb00160.x","volume":"14","author":"DN Sgouras","year":"1995","unstructured":"Sgouras, D. N. et al. ERF: an ets domain protein with strong transcriptional repressor activity, can suppress ets\u2013associated tumorigenesis and is regulated by phosphorylation during cell cycle and mitogenic stimulation. EMBO J. 14, 4781\u20134793 (1995).","journal-title":"EMBO J."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrd1085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd1085","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrd1085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T16:40:25Z","timestamp":1704818425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd1085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":136,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5,1]]}},"alternative-id":["BFnrd1085"],"URL":"https:\/\/doi.org\/10.1038\/nrd1085","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]}}}